North America Cellulite Treatment Market Size, Share & Trends Analysis Report By Gender (Female and Male), By Procedure Type, By Cellulite Type, By End User (Clinics & Beauty Centers, Hospitals and Others). By Country and Growth Forecast, 2024 - 2031

The North America Cellulite Treatment Market would witness market growth of 9.5% CAGR during the forecast period (2024-2031).

The US market dominated the North America Cellulite Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,828.3 Million by 2031. The Canada market is experiencing a CAGR of 10% during (2024 - 2031). Additionally, The Mexico market would experience a CAGR of 10.5% during (2024 - 2031).

Cellulite, often described as the dimpled or lumpy appearance of the skin, affects a large percentage of the population, particularly women, and is commonly found on the thighs, hips, buttocks, and abdomen. Although cellulite does not pose any health risks, it can significantly impair an individual's self-esteem and body image, prompting considerable interest in exploring treatment alternatives.

According to the National Library of Medicine, very little is known about the prevalence and incidence of cellulite and the predisposing factors for cellulite development because of a lack of robust epidemiologic data. Despite this shortcoming, it is widely reported in the literature that an estimated 80% to 90% of postpubertal females are affected by this condition. There is no particular age of onset for cellulite. It can occur at any age postpuberty, although it mostly appears between the ages of 20 and 30. Males are rarely affected by cellulite. In about 2% of males, cellulite may develop due to androgen deficiency secondary to castration, hypogonadism, Klinefelter's syndrome, or estrogen or antiandrogen therapy for prostate cancer.

The increasing demand for cellulite treatment in the US can be linked to the significant growth in the older population. The US Census Bureau estimates that between 1920 and 2020, the population over 65 grew by 50.9 million, or nearly five times the overall population growth rate of approximately 1,000%. Therefore, because of these elements, the regional market will grow rapidly in the coming years.

Free Valuable Insights: The Cellulite Treatment Market is Predict to reach USD 5.4 Billion by 2031, at a CAGR of 10.1%

Based on Gender, the market is segmented into Female and Male. Based on Procedure Type, the market is segmented into Non-invasive, Topical, and Minimally Invasive. Based on Cellulite Type, the market is segmented into Soft Cellulite, Hard Cellulite and Edematous. Based on End User, the market is segmented into Clinics & Beauty Centers, Hospitals and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Candela Corporation (Syneron Medical)
• Bausch Health Companies, Inc.
• Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
• AbbVie, Inc.
• Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
• Hologic, Inc.
• Galderma S.A.
• Zimmer MedizinSysteme GmbH
• Endo International PLC
• Merz Pharma GmbH & Co. KGaA

North America Cellulite Treatment Market Report Segmentation

By Gender

• Female
• Male

By Procedure Type

• Non-invasive
• Topical
• Minimally Invasive

By Cellulite Type

• Soft Cellulite
• Hard Cellulite
• Edematous

By End User

• Clinics & Beauty Centers
• Hospitals
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cellulite Treatment Market, by Gender
1.4.2 North America Cellulite Treatment Market, by Procedure Type
1.4.3 North America Cellulite Treatment Market, by Cellulite Type
1.4.4 North America Cellulite Treatment Market, by End User
1.4.5 North America Cellulite Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. Recent Strategies Deployed in Cellulite Treatment Market

Chapter 5. North America Cellulite Treatment Market by Gender
5.1 North America Female Market by Region
5.2 North America Male Market by Region

Chapter 6. North America Cellulite Treatment Market by Procedure Type
6.1 North America Non-invasive Market by Country
6.2 North America Topical Market by Country
6.3 North America Minimally Invasive Market by Country

Chapter 7. North America Cellulite Treatment Market by Cellulite Type
7.1 North America Soft Cellulite Market by Country
7.2 North America Hard Cellulite Market by Country
7.3 North America Edematous Market by Country

Chapter 8. North America Cellulite Treatment Market by End User
8.1 North America Clinics & Beauty Centers Market by Country
8.2 North America Hospitals Market by Country
8.3 North America Others Market by Country

Chapter 9. North America Cellulite Treatment Market by Country
9.1 US Cellulite Treatment Market
9.1.1 US Cellulite Treatment Market by Gender
9.1.2 US Cellulite Treatment Market by Procedure Type
9.1.3 US Cellulite Treatment Market by Cellulite Type
9.1.4 US Cellulite Treatment Market by End User
9.2 Canada Cellulite Treatment Market
9.2.1 Canada Cellulite Treatment Market by Gender
9.2.2 Canada Cellulite Treatment Market by Procedure Type
9.2.3 Canada Cellulite Treatment Market by Cellulite Type
9.2.4 Canada Cellulite Treatment Market by End User
9.3 Mexico Cellulite Treatment Market
9.3.1 Mexico Cellulite Treatment Market by Gender
9.3.2 Mexico Cellulite Treatment Market by Procedure Type
9.3.3 Mexico Cellulite Treatment Market by Cellulite Type
9.3.4 Mexico Cellulite Treatment Market by End User
9.4 Rest of North America Cellulite Treatment Market
9.4.1 Rest of North America Cellulite Treatment Market by Gender
9.4.2 Rest of North America Cellulite Treatment Market by Procedure Type
9.4.3 Rest of North America Cellulite Treatment Market by Cellulite Type
9.4.4 Rest of North America Cellulite Treatment Market by End User

Chapter 10. Company Profiles
10.1 Candela corporation (Syneron Medical)
10.1.1 Company Overview
10.1.2 Recent strategies and developments:
10.1.2.1 Partnerships, Collaborations, and Agreements:
10.1.2.2 Product Launches and Product Expansions:
10.1.3 SWOT Analysis
10.2 Bausch Health Companies, Inc
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Trials and Approvals:
10.2.6 SWOT Analysis
10.3 Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
10.3.1 Company Overview
10.3.2 Recent strategies and developments:
10.3.2.1 Partnerships, Collaborations, and Agreements:
10.3.2.2 Product Launches and Product Expansions:
10.3.3 SWOT Analysis
10.4 AbbVie, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Product Launches and Product Expansions:
10.4.5.2 Acquisition and Mergers:
10.4.6 SWOT Analysis
10.5 Hologic, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 SWOT Analysis
10.6 Galderma S.A.
10.6.1 Company Overview
10.6.2 SWOT Analysis
10.7 Endo International PLC
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental Analysis
10.7.4 Research & Development Expense
10.7.5 Recent strategies and developments:
10.7.5.1 Trials and Approvals:
10.7.5.2 Acquisition and Mergers:
10.7.6 SWOT Analysis
10.8 Merz Pharma GmbH & Co. KGaA
10.8.1 Company Overview
10.8.2 SWOT Analysis
10.9 Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
10.9.1 Company Overview
10.9.2 SWOT Analysis
10.10. Zimmer MedizinSysteme GmbH
10.10.1 Company Overview
10.10.2 SWOT Analysis

TABLE 1 North America Cellulite Treatment Market, 2020 - 2023, USD Million
TABLE 2 North America Cellulite Treatment Market, 2024 - 2031, USD Million
TABLE 3 North America Cellulite Treatment Market by Gender, 2020 - 2023, USD Million
TABLE 4 North America Cellulite Treatment Market by Gender, 2024 - 2031, USD Million
TABLE 5 North America Female Market by Region, 2020 - 2023, USD Million
TABLE 6 North America Female Market by Region, 2024 - 2031, USD Million
TABLE 7 North America Male Market by Region, 2020 - 2023, USD Million
TABLE 8 North America Male Market by Region, 2024 - 2031, USD Million
TABLE 9 North America Cellulite Treatment Market by Procedure Type, 2020 - 2023, USD Million
TABLE 10 North America Cellulite Treatment Market by Procedure Type, 2024 - 2031, USD Million
TABLE 11 North America Non-invasive Market by Country, 2020 - 2023, USD Million
TABLE 12 North America Non-invasive Market by Country, 2024 - 2031, USD Million
TABLE 13 North America Topical Market by Country, 2020 - 2023, USD Million
TABLE 14 North America Topical Market by Country, 2024 - 2031, USD Million
TABLE 15 North America Minimally Invasive Market by Country, 2020 - 2023, USD Million
TABLE 16 North America Minimally Invasive Market by Country, 2024 - 2031, USD Million
TABLE 17 North America Cellulite Treatment Market by Cellulite Type, 2020 - 2023, USD Million
TABLE 18 North America Cellulite Treatment Market by Cellulite Type, 2024 - 2031, USD Million
TABLE 19 North America Soft Cellulite Market by Country, 2020 - 2023, USD Million
TABLE 20 North America Soft Cellulite Market by Country, 2024 - 2031, USD Million
TABLE 21 North America Hard Cellulite Market by Country, 2020 - 2023, USD Million
TABLE 22 North America Hard Cellulite Market by Country, 2024 - 2031, USD Million
TABLE 23 North America Edematous Market by Country, 2020 - 2023, USD Million
TABLE 24 North America Edematous Market by Country, 2024 - 2031, USD Million
TABLE 25 North America Cellulite Treatment Market by End User, 2020 - 2023, USD Million
TABLE 26 North America Cellulite Treatment Market by End User, 2024 - 2031, USD Million
TABLE 27 North America Clinics & Beauty Centers Market by Country, 2020 - 2023, USD Million
TABLE 28 North America Clinics & Beauty Centers Market by Country, 2024 - 2031, USD Million
TABLE 29 North America Hospitals Market by Country, 2020 - 2023, USD Million
TABLE 30 North America Hospitals Market by Country, 2024 - 2031, USD Million
TABLE 31 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 32 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 33 North America Cellulite Treatment Market by Country, 2020 - 2023, USD Million
TABLE 34 North America Cellulite Treatment Market by Country, 2024 - 2031, USD Million
TABLE 35 US Cellulite Treatment Market, 2020 - 2023, USD Million
TABLE 36 US Cellulite Treatment Market, 2024 - 2031, USD Million
TABLE 37 US Cellulite Treatment Market by Gender, 2020 - 2023, USD Million
TABLE 38 US Cellulite Treatment Market by Gender, 2024 - 2031, USD Million
TABLE 39 US Cellulite Treatment Market by Procedure Type, 2020 - 2023, USD Million
TABLE 40 US Cellulite Treatment Market by Procedure Type, 2024 - 2031, USD Million
TABLE 41 US Cellulite Treatment Market by Cellulite Type, 2020 - 2023, USD Million
TABLE 42 US Cellulite Treatment Market by Cellulite Type, 2024 - 2031, USD Million
TABLE 43 US Cellulite Treatment Market by End User, 2020 - 2023, USD Million
TABLE 44 US Cellulite Treatment Market by End User, 2024 - 2031, USD Million
TABLE 45 Canada Cellulite Treatment Market, 2020 - 2023, USD Million
TABLE 46 Canada Cellulite Treatment Market, 2024 - 2031, USD Million
TABLE 47 Canada Cellulite Treatment Market by Gender, 2020 - 2023, USD Million
TABLE 48 Canada Cellulite Treatment Market by Gender, 2024 - 2031, USD Million
TABLE 49 Canada Cellulite Treatment Market by Procedure Type, 2020 - 2023, USD Million
TABLE 50 Canada Cellulite Treatment Market by Procedure Type, 2024 - 2031, USD Million
TABLE 51 Canada Cellulite Treatment Market by Cellulite Type, 2020 - 2023, USD Million
TABLE 52 Canada Cellulite Treatment Market by Cellulite Type, 2024 - 2031, USD Million
TABLE 53 Canada Cellulite Treatment Market by End User, 2020 - 2023, USD Million
TABLE 54 Canada Cellulite Treatment Market by End User, 2024 - 2031, USD Million
TABLE 55 Mexico Cellulite Treatment Market, 2020 - 2023, USD Million
TABLE 56 Mexico Cellulite Treatment Market, 2024 - 2031, USD Million
TABLE 57 Mexico Cellulite Treatment Market by Gender, 2020 - 2023, USD Million
TABLE 58 Mexico Cellulite Treatment Market by Gender, 2024 - 2031, USD Million
TABLE 59 Mexico Cellulite Treatment Market by Procedure Type, 2020 - 2023, USD Million
TABLE 60 Mexico Cellulite Treatment Market by Procedure Type, 2024 - 2031, USD Million
TABLE 61 Mexico Cellulite Treatment Market by Cellulite Type, 2020 - 2023, USD Million
TABLE 62 Mexico Cellulite Treatment Market by Cellulite Type, 2024 - 2031, USD Million
TABLE 63 Mexico Cellulite Treatment Market by End User, 2020 - 2023, USD Million
TABLE 64 Mexico Cellulite Treatment Market by End User, 2024 - 2031, USD Million
TABLE 65 Rest of North America Cellulite Treatment Market, 2020 - 2023, USD Million
TABLE 66 Rest of North America Cellulite Treatment Market, 2024 - 2031, USD Million
TABLE 67 Rest of North America Cellulite Treatment Market by Gender, 2020 - 2023, USD Million
TABLE 68 Rest of North America Cellulite Treatment Market by Gender, 2024 - 2031, USD Million
TABLE 69 Rest of North America Cellulite Treatment Market by Procedure Type, 2020 - 2023, USD Million
TABLE 70 Rest of North America Cellulite Treatment Market by Procedure Type, 2024 - 2031, USD Million
TABLE 71 Rest of North America Cellulite Treatment Market by Cellulite Type, 2020 - 2023, USD Million
TABLE 72 Rest of North America Cellulite Treatment Market by Cellulite Type, 2024 - 2031, USD Million
TABLE 73 Rest of North America Cellulite Treatment Market by End User, 2020 - 2023, USD Million
TABLE 74 Rest of North America Cellulite Treatment Market by End User, 2024 - 2031, USD Million
TABLE 75 Key Information – candela corporation
TABLE 76 key information – Bausch Health Companies, Inc.
TABLE 77 Key Information – Sinclair Pharma Ltd.
TABLE 78 Key information – AbbVie, Inc.
TABLE 79 Key Information – Hologic, Inc.
TABLE 80 Key Information – Galderma S.A.
TABLE 81 Key Information – Endo International PLC
TABLE 82 Key information – Merz Pharma GmbH & Co. KGaA
TABLE 83 Key Information – Cynosure, LLC
TABLE 84 Key Information – Zimmer MedizinSysteme GmbH

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Cellulite Treatment Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Cellulite Treatment Market
FIG 4 Porter’s Five Forces Analysis - Cellulite Treatment Market
FIG 5 North America Cellulite Treatment Market share by Gender, 2023
FIG 6 North America Cellulite Treatment Market share by Gender, 2031
FIG 7 North America Cellulite Treatment Market by Gender, 2020 - 2031, USD Million
FIG 8 North America Cellulite Treatment Market share by Procedure Type, 2023
FIG 9 North America Cellulite Treatment Market share by Procedure Type, 2031
FIG 10 North America Cellulite Treatment Market by Procedure Type, 2020 - 2031, USD Million
FIG 11 North America Cellulite Treatment Market share by Cellulite Type, 2023
FIG 12 North America Cellulite Treatment Market share by Cellulite Type, 2031
FIG 13 North America Cellulite Treatment Market by Cellulite Type, 2020 - 2031, USD Million
FIG 14 North America Cellulite Treatment Market share by End User, 2023
FIG 15 North America Cellulite Treatment Market share by End User, 2031
FIG 16 North America Cellulite Treatment Market by End User, 2020 - 2031, USD Million
FIG 17 North America Cellulite Treatment Market share by Country, 2023
FIG 18 North America Cellulite Treatment Market share by Country, 2031
FIG 19 North America Cellulite Treatment Market by Country, 2020 - 2031, USD Million
FIG 20 Recent strategies and developments: Candela Corporation
FIG 21 SWOT Analysis: Candela Corporation
FIG 22 SWOT Analysis: Bausch Health Companies, Inc.
FIG 23 Recent strategies and developments: Sinclair Pharma Ltd.
FIG 24 SWOT Analysis: Sinclair Pharma Ltd.
FIG 25 Recent strategies and developments: AbbVie Inc.
FIG 26 Swot Analysis: AbbVie, Inc.
FIG 27 Swot Analysis: Hologic, Inc.
FIG 28 SWOT Analysis: Galderma S.A.
FIG 29 Recent strategies and developments: Endo International Plc
FIG 30 SWOT Analysis: Endo International PLC
FIG 31 SWOT Analysis: Merz Pharma GmbH & Co. KGaA
FIG 32 Swot Analysis: CYNOSURE, LLC
FIG 33 SWOT Analysis: Zimmer MedizinSysteme GmbH